These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26188518)

  • 21. The inositol phosphatase SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain.
    Soeda Y; Tsuneki H; Muranaka H; Mori N; Hosoh S; Ichihara Y; Kagawa S; Wang X; Toyooka N; Takamura Y; Uwano T; Nishijo H; Wada T; Sasaoka T
    Mol Endocrinol; 2010 Oct; 24(10):1965-77. PubMed ID: 20829391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
    Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SH2-containing inositol 5'-phosphatase 2 selectively impairs hypothalamic insulin signalling and regulation of food intake in mice.
    Ichihara Y; Wada T; Soeda Y; Ishii Y; Sasahara M; Tsuneki H; Sasaoka T
    J Neuroendocrinol; 2013 Apr; 25(4):372-82. PubMed ID: 23286299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.
    Pesesse X; Moreau C; Drayer AL; Woscholski R; Parker P; Erneux C
    FEBS Lett; 1998 Oct; 437(3):301-3. PubMed ID: 9824312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional profiling of C2C12 myotubes in response to SHIP2 depletion and insulin stimulation.
    Huard C; Martinez RV; Ross C; Johnson JW; Zhong W; Hill AA; Kim R; Paulsen JE; Shih HH
    Genomics; 2007 Feb; 89(2):270-9. PubMed ID: 17123777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of lipid phosphatases SHIP2 and PTEN on the time- and Akt-isoform-specific amelioration of TNF-alpha-induced insulin resistance in 3T3-L1 adipocytes.
    Ikubo M; Wada T; Fukui K; Ishiki M; Ishihara H; Asano T; Tsuneki H; Sasaoka T
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E157-64. PubMed ID: 19001549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of activating transcription factor 4 signaling on lipogenesis in HepG2 cells.
    Ren LP; Yu X; Song GY; Zhang P; Sun LN; Chen SC; Hu ZJ; Zhang XM
    Mol Med Rep; 2016 Aug; 14(2):1649-58. PubMed ID: 27357269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific tyrosine phosphorylations mediate signal-dependent stimulation of SHIP2 inositol phosphatase activity, while the SH2 domain confers an inhibitory effect to maintain the basal activity.
    Prasad NK; Werner ME; Decker SJ
    Biochemistry; 2009 Jul; 48(27):6285-7. PubMed ID: 19518129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IRTKS Promotes Insulin Signaling Transduction through Inhibiting SHIP2 Phosphatase Activity.
    Wu C; Cui X; Huang L; Shang X; Wu B; Wang N; He K; Han Z
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
    Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
    Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lipid phosphatase SHIP2 controls insulin sensitivity.
    Clément S; Krause U; Desmedt F; Tanti JF; Behrends J; Pesesse X; Sasaki T; Penninger J; Doherty M; Malaisse W; Dumont JE; Le Marchand-Brustel Y; Erneux C; Hue L; Schurmans S
    Nature; 2001 Jan; 409(6816):92-7. PubMed ID: 11343120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense oligonucleotides against the lipid phosphatase SHIP2 improve muscle insulin sensitivity in a dietary rat model of the metabolic syndrome.
    Buettner R; Ottinger I; Gerhardt-Salbert C; Wrede CE; Schölmerich J; Bollheimer LC
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1871-8. PubMed ID: 17327370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic PTP-1B expression regulates the assembly and secretion of apolipoprotein B-containing lipoproteins: evidence from protein tyrosine phosphatase-1B overexpression, knockout, and RNAi studies.
    Qiu W; Avramoglu RK; Dubé N; Chong TM; Naples M; Au C; Sidiropoulos KG; Lewis GF; Cohn JS; Tremblay ML; Adeli K
    Diabetes; 2004 Dec; 53(12):3057-66. PubMed ID: 15561934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2.
    Suwa A; Yamamoto T; Sawada A; Minoura K; Hosogai N; Tahara A; Kurama T; Shimokawa T; Aramori I
    Br J Pharmacol; 2009 Oct; 158(3):879-87. PubMed ID: 19694723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of denervation-induced insulin resistance by SHIP2 protein synthesis blockade.
    Bertelli DF; Ueno M; Amaral ME; Toyama MH; Carneiro EM; Marangoni S; Carvalho CR; Saad MJ; Velloso LA; Boschero AC
    Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E679-87. PubMed ID: 12453826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes.
    Zhang Y; Lei T; Huang JF; Wang SB; Zhou LL; Yang ZQ; Chen XD
    Mol Cell Endocrinol; 2011 Aug; 342(1-2):41-7. PubMed ID: 21664250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.
    Sasaoka T; Wada T; Tsuneki H
    Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation.
    Zhuang G; Hunter S; Hwang Y; Chen J
    J Biol Chem; 2007 Jan; 282(4):2683-94. PubMed ID: 17135240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
    Qin B; Anderson RA; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
    Artemenko Y; Gagnon A; Sorisky A
    J Cell Physiol; 2009 Jan; 218(1):228-36. PubMed ID: 18814181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.